The #1 Trusted Red Light & Infrared Technology in the World for over 25 Years! Use Code SPRING2025 for 20% discount!

 

 

  • Application of ozone therapy in interventional medicine

  •  

 

Abstract

 

Ozone therapy has been gradually accepted by doctors in various fields because it has been safe, convenient, and inexpensive since the twentieth century. It has been used in the treatment of various diseases with satisfactory results, especially in the application of interventional surgery. For lumbar disc herniation, knee osteoarthritis, tissue ischemia-reperfusion after revascularization, stroke, and cancer, ozone therapy can improve the efficacy of interventional surgery and reduce postoperative acute and chronic complications. Prospects of ozone therapy in interventional therapy and the underlying mechanisms of efficacy need further exploration.

 

Keywords: Ozone therapy, Interventional therapy, Lumbar disc herniation, Knee osteoarthritis, Tissue ischemia-reperfusion, Stroke, Cancer


Ozone is an unstable gas comprising three oxygen atoms, and it is more soluble in water than oxygen. Ozone was used in medicine initially in the early twentieth century. Early on, it was used to treat gangrene in the wounded during the First World War. After the war, it was applied in wound disinfection, wound healing, hepatitis, arthritis, lumbar disc herniation, and other diseases. Doctors often achieved satisfactory effects. Ozone therapy has gradually become accepted as a non-traditional treatment because of its safety, convenience, low cost, and other advantages.

 

1. Lumbar disc herniation

 

Low back pain is a very common disorder with significant impact on patients’ clinical status. It is the fifth most prevalent condition that is treated in the world. The prevalence is estimated at 22–65% per year, and 90% of adults have had low back pain symptoms during their lives., The management of low back pain should always start with a conservative approach; however, when this fails, minimally invasive techniques should be adopted before invasive surgery.

 

Intervertebral disc and peripheral nerve root ozone injection has become a common treatment for herniated discs. It is widely prescribed in various countries of Europe, Asia, and South America; more than 600 treatments are performed every day in China alone., Intervertebral disc ozone injections are the most common treatment, followed by injection around the nerve root. Intra-disc injection of ozone can be considered for refractory discogenic sciatica for short and medium term pain in patients and is a minimally invasive, safe, and effective treatment., , , Most of the treatment is conducted under the digital subtraction angiography (DSA) with different ozone gas concentrations of 25, 30, 40 μg/ml.,, A small amount can be administered under the guidance of computed tomography (CT)., We typically use 35 μg/ml, and there were no significant differences among these concentrations.

 

There have been some new developments for the ozone therapy of lumbar disc herniation in recent years. Studies have shown that the patients with ozone injection monotherapy have marked pain relief, and the degree of mitigation is greater than that achieved with more conservative medical treatment. Clinical trials have confirmed that its efficacy is better than laser disc decompression. Furthermore, ozone monotherapy showed no significant difference with ozone ​+ ​betamethasone combination therapy in postoperative pain relief, which suggests that ozone has excellent performance in pain relief., By comparing the effects of ozone injection and the emerging Souchard's global postural re-education (GPR), it was confirmed that ozone ablation is better than GPR, and maintains long-term efficacy. For the patients with lumbar disc herniation, ozone therapy can reduce the pain caused by nerve root compression and inflammatory stimulation, and have better prevention effects for motor weakness caused by nerve root symptoms. Ozone treatment substantially mitigates symptoms of motor weakness. Clinicians have also used ozone injection combined with radiofrequency ablation of intervertebral disc. Although the combination did not show a clear advantage over radiofrequency ablation alone one month later, according to the one-year follow-up results, combination therapy has a stronger effect in alleviating pain than radiofrequency ablation alone. A magnetic resonance imaging (MRI) T2 weighted image (T2WI) can be used to evaluate the efficacy of intervertebral disc ozone therapy.

 

After years of exploration, some mechanisms of ozone treatment of lumbar disc herniation have been elucidated. Ozone not only inhibits local inflammatory response and alleviates hypoxia symptoms, but also damages muopolysaccharide chains in the nucleus pulposus and reduces its water content, resulting in a reduction in the size of the nucleus pulposus (which has been confirmed by CT and MRI T2WI), which can mitigate the symptoms of pressure and stimulate fibroblast proliferation. Therefore, ozone therapy contributes to repair and restores the patient's overall oxidative stress balance.

 

The analgesic mechanism induced by O3 may involve two independent steps: a short-term mechanism that may correspond with the direct oxidation of biomolecules and a long-term mechanism that may involve the activation of antioxidant pathways. Further studies are needed to support the biochemical analgesic mechanism of O3 therapy.

 

2. Knee osteoarthritis

 

Knee osteoarthritis (KOA) is a common disease, imposing a great burden through pain and decreased function. Numerous methods have been tested for pain management in KOA, and the optimal method is currently still under debate. Intra-articular injection of hyaluronic acid (HA) was associated with a significant reduction in visual analog scale score at 1 month compared to oxygen-ozone. However, intra-articular ozone injections after arthroscopic surgery may effectively improve the outcomes of arthroscopic surgery in terms of pain relief, functional improvement, and quality of life in patients with KOA of Kellgren-Lawrence grade II or III. Intra-articular injection of ozone plus oral celecoxib and glucosamine significantly decreased pain intensity in patients with mild to moderate KOA and improved their functional status sooner than oral celecoxib and glucosamine alone. The combination of O2–O3 and HA treatment led to significantly better outcomes compared to HA and O2–O3 given separately to patients affected by KOA. Intra-articular injection has not changed the serum concentrations of TNF-α, TNFR I, and TNFR II, but their synovial concentrations showed significant changes; the synovial TNFR I was significantly higher.

 

3. Tissue ischemia-reperfusion

 

In peripheral, craniocerebral, and cardiac interventional procedures, we often encounter vascular occlusions that require us to perform complex re-operations, such as catheter embolization, balloon dilatation, and stent implantation. However, the ischemia-reperfusion injury that occurs after successful operation on the blood vessels in our surgery is problematic. How can we better reduce the impact of ischemia-reperfusion injury on the limbs or organs of patients?

 

Ozone is a strongly oxidizing gas, early experiments found that it can activate the body's oxidative stress defense system, stimulate the expression of nuclear factor erythroid 2–related factor 2 (Nrf2)/electrophile-responsive element (EpRE) by activating extracellularly regulated protein kinases and P38. Ozone can also promote the activity of superoxide dismutase and catalase., , Autohemotherapy, a treatment of disease by modification (as by ozone) of the patient's own blood, not only reduces the blood creatinine and urea nitrogen concentration from renal ischemia-reperfusion, but also protects the kidney tissue structure. Previously, it was thought that ozone regulated the NO pathway. However, now the hypothesis is that ozone stimulates increases in local β-NADPH-lipoamide dehydrogenase concentration. Autohemotherapy of human umbilical vein endothelial cells significantly increases both the rate of oxygen consumption and the mitochondrial activity as assessed by confocal microscopy. Subsequent studies have shown that ozone modulates the accumulation of local neutrophils, the expression of IL-6, TNF-α, and ischemia-modified albumin in the kidneys and increases the total local antioxidant capacity. Ozone therapy protects the tissue by reducing creatine kinase, aspartate aminotransferase, and K+ ions in the muscle,, and decreasing mitochondrial damage caused by ischemia-reperfusion injury (IRI). Ozone also inhibited the release of cytochrome-c from the mitochondria to the cytoplasm in SH-SY5Y cells. Apoptosis caused by IRI was inhibited by ozone, and ozone decreased apoptosis by increasing the ratio of Bcl-2/Bax and inhibiting the caspase signaling pathway in SH-SY5Y cells. Ozone also prevented the elevation of blood urea nitrogen and creatinine, renal damage, and pyroptosis. Oxidative stress and pyroptosis were increased in the hypoxia and reoxygenation (H/R) model using NRK-52E cells. Ozone oxidative preconditioning increased the expression of Nrf2 and decreased the levels of nucleotide-binding domain, leucine-rich repeat family pyrin domain-containing 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), un-cleavable cysteine-requiring aspartate protease-1 (procaspase-1), cysteine-requiring aspartate protease-1 (caspase-1), and interleukin-1β (IL-1β), and increased antioxidant capacity and to protect the myocardium and lung against IRI. A study about major ozonated autohemotherapy (MOA) showed that it attenuated renal IRI in rabbits shows that oxidative stress, neutrophil to lymphocyte ratio (NLR), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), ischemia-modified albumin (IMA), total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) have been increased. Intestinal ischemia-reperfusion injury is associated with mucosal damage and has a high rate of mortality. Ozone therapy prevented IRI by mitigating IR-associated tissue injury.

 

4. Stroke

Stroke is the second leading cause

of death and disability in the world. Neurointervention has gradually become one of the main treatments in stroke treatment, but postoperative sequelae are still an urgent problem. Major ozonated autohemotherapy treatment in patients with acute cerebral infarction shows satisfactory results. It maintains ATP and energy metabolism in cerebral ischemia and hypoxia, and reduces cell apoptosis. Doctors from Guangzhou General Hospital of Guangzhou Military Command assessed the outcomes according to the U.S. National Institutes of Health Stroke Score, Modified Rankin Scale, and transcranial magnetic stimulation motor-evoked potential. Major ozonated autohemotherapy may promote motor function recovery of the upper limb in patients with acute cerebral infarction. Reduced degree of fractional anisotropy values of brain magnetic resonance diffusion tensor imaging were remarkably decreased, and brain function improved. Therefore, it is a good choice to give ozone treatment after stroke.

 

5. Cancer

 

Tumor treatment is a difficult problem. The best known interventions for tumors are surgery, which is highly invasive, and chemotherapy, which has intense side effects. In recent years, interventional therapy has become an indispensable treatment method due to minimal invasiveness and side effects. Ozone treatment has shown excellent auxiliary effects in cancer treatment. It is not only effective against papillomavirus-induced lesions, particularly against those induced by the most common high-risk virus, HPV16, but also a valid supportive therapy for fatigue in cancer patients, both during cancer therapy and in a palliative setting with no significant side effects. Ozone could be useful in colon cancer management in combination with 5-fluorouracil and cisplatin by significantly inhibiting cytokines that have a central role in colon cancer cell survival and chemoresistance. The use of ozone therapy in these patients enhances the action of chemotherapy and at the same time reduces side effects, such as nausea, vomiting, opportunistic infections, buccal ulcers, hair loss, and fatigue. Such positive therapeutic effects of ozone therapy can improve broader physical and mental wellbeing, resulting in improved quality of life.

Ozone can also prevent side effects of some chemotherapy drugs, such as preventing doxorubicin-induced dilated cardiomyopathy through an increase of antioxidant enzymes and a reduction of oxidized macromolecules. Preconditioning and treatment with ozone attenuated the nephrotoxicity induced by methotrexate in rats by activating antioxidant enzymes and preventing renal tissue damage. In addition, some scholars have applied ozonated saline to treat VX2 tumors. Ozonated saline at 20 μg/mL and 40 μg/mL were directly injected into the tumors respectively (injection volume = 1/2 volume of the tumor); tumor-growth was controlled in the near term, but due to the production of sodium hypochlorite in ozonated saline, long-term use may cause cancer. Therefore, it is not recommended for clinical application.

In summary, ozone therapy, like interventional therapy, is a new treatment in the long history of human medicine, and it needs further exploration and research. Ozone is currently used in a wide range of interventional therapies. It can help interventionalists achieve better results in the treatment of various diseases.

 

Conflicts of interest

 

The authors declare that they have no conflicts of interest.

 

 

Funding

 

There was no funding support for the work herein.

 

Informed consent

 

Not applicable.

 

Acknowledgments

 

We thank Zhao Wei and Pang Huajin for their constructive discussions.

References

 

  • 1.Zanardi I., Borrelli E., Valacchi G. Ozone: a multifaceted molecule with unexpected therapeutic activity. Curr Med Chem. 2016;23(4):304–314. doi: 10.2174/0929867323666151221150420. [DOI] [PubMed] [Google Scholar]
  • 2.Apuzzo D., Giotti C., Pasqualetti P. An observational retrospective/horizontal study to compare oxygen-ozone therapy and/or global postural re-education in complicated chronic low back pain. Funct Neurol. 2014;29(1):31–39. [PMC free article] [PubMed] [Google Scholar]
  • 3.Hashemi M., Poorfarokh M., Mohajerani S.A. Injection of intradiscal o2-o3 to reduce pain and disability of patients with low back pain due to prolapsed lumbar disk. Anesthesiol Pain Med. 2014;4(5) doi: 10.5812/aapm.19206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Giurazza F., Guarnieri G., Murphy K.J. Intradiscal O2O3: rationale, injection technique, short- and long-term outcomes for the treatment of low back pain due to disc herniation. Can Assoc Radiol J. 2017;68(2):171–177. doi: 10.1016/j.carj.2016.12.007. [DOI] [PubMed] [Google Scholar]
  • 5.Costa T., Linhares D., Ribeiro D.S.M. Ozone therapy for low back pain. A systematic review. Acta Reumatol Port. 2018;43(3):172–181. [PubMed] [Google Scholar]
  • 6.Vanni D., Galzio R., Kazakova A. Intraforaminal ozone therapy and particular side effects: preliminary results and early warning. Acta Neurochir. 2016;158(5):991–993. doi: 10.1007/s00701-016-2755-y. [DOI] [PubMed] [Google Scholar]
  • 7.Crockett M.T., Moynagh M., Long N. Ozone-augmented percutaneous discectomy: a novel treatment option for refractory discogenic sciatica. Clin Radiol. 2014;69(12):1280–1286. doi: 10.1016/j.crad.2014.08.008. [DOI] [PubMed] [Google Scholar]
  • 8.Yu Z., Luo W., Wang B. Targeted injection of ozone through the posterior approach via the spinal canal and dural sac for treating lumbar disc herniation. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32(2):243–246. [PubMed] [Google Scholar]
  • 9.Bocci V., Borrelli E., Zanardi I. The usefulness of ozone treatment in spinal pain. Drug Des Dev Ther. 2015;9:2677–2685. doi: 10.2147/DDDT.S74518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Murphy K., Muto M., Steppan J. Treatment of contained herniated lumbar discs with ozone and corticosteroid: a pilot clinical study. Can Assoc Radiol J. 2015;66(4):377–384. doi: 10.1016/j.carj.2015.01.003. [DOI] [PubMed] [Google Scholar]
  • 11.Ozcan S., Muz A., Yildiz A.A. Intradiscal ozone therapy for lumbar disc herniation. Cell Mol Biol (Noisy-le-grand) 2018;64(5):52–55. [PubMed] [Google Scholar]
  • 12.Rahimzadeh P., Imani F., Ghahremani M. Comparison of percutaneous intradiscal ozone injection with laser disc decompression in discogenic low back pain. J Pain Res. 2018;11:1405–1410. doi: 10.2147/JPR.S164335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lehnert T., Naguib N.N., Wutzler S. Analysis of disk volume before and after CT-guided intradiscal and periganglionic ozone-oxygen injection for the treatment of lumbar disk herniation. J Vasc Interv Radiol. 2012;23(11):1430–1436. doi: 10.1016/j.jvir.2012.07.029. [DOI] [PubMed] [Google Scholar]
  • 14.Elawamy A., Kamel E.Z., Hassanien M. Implication of two different doses of intradiscal ozone-oxygen injection upon the pain alleviation in patients with low back pain: a randomized, single-blind study. Pain Physician. 2018;21(1):E25–E31. [PubMed] [Google Scholar]
  • 15.Melchionda D., Milillo P., Manente G. Treatment of radiculopathies: a study of efficacy and tollerability of paravertebral oxygen-ozone injections compared with pharmacological anti-inflammatory treatment. J Biol Regul Homeost Agents. 2012;26(3):467–474. [PubMed] [Google Scholar]
  • 16.Zhang Y., Ma Y., Jiang J. Treatment of the lumbar disc herniation with intradiscal and intraforaminal injection of oxygen-ozone. J Back Musculoskelet Rehabil. 2013;26(3):317–322. doi: 10.3233/BMR-130386. [DOI] [PubMed] [Google Scholar]
  • 17.Apuzzo D., Giotti C., Pasqualetti P. An observational retrospective/horizontal study to compare oxygen-ozone therapy and/or global postural re-education in complicated chronic low back pain. Funct Neurol. 2014;29(1):31–39. [PMC free article] [PubMed] [Google Scholar]
  • 18.Ren X.C., Wang X.Y., Zhang S.H. [Treatment of lumbar intervertebral disc herniation with coblation combined with ozone nucleus pulposus ablation] Zhong Guo Gu Shang. 2013;26(10):815–818. [PubMed] [Google Scholar]
  • 19.Perri M., Grattacaso G., di Tunno V. T2 shine-through phenomena in diffusion-weighted MR imaging of lumbar discs after oxygen-ozone discolysis: a randomized, double-blind trial with steroid and O2-O3 discolysis versus steroid only. Radiol Med. 2015;120(10):941–950. doi: 10.1007/s11547-015-0519-z. [DOI] [PubMed] [Google Scholar]
  • 20.Rahimi-Movaghar V., Eslami V. The major efficient mechanisms of ozone therapy are obtained in intradiscal procedures. Pain Physician. 2012;15(6):E1007–E1008. [PubMed] [Google Scholar]
  • 21.Leon F.O., Pantoja M., Diaz S.M. Ozone oxidative post-conditioning reduces oxidative protein damage in patients with disc hernia. Neurol Res. 2012;34(1):59–67. doi: 10.1179/1743132811Y.0000000060. [DOI] [PubMed] [Google Scholar]
  • 22.Re L., Sanchez G.M., Mawsouf N. Clinical evidence of ozone interaction with pain mediators. Saudi Med J. 2010;31(12):1363–1367. [PubMed] [Google Scholar]
  • 23.Li Q., Qi X., Zhang Z. Intra-articular oxygen-ozone versus hyaluronic acid in knee osteoarthritis: a meta-analysis of randomized controlled trials. Int J Surg. 2018;58:3–10. doi: 10.1016/j.ijsu.2018.08.007. [DOI] [PubMed] [Google Scholar]
  • 24.Wang X., Wang G., Liu C. Effectiveness of intra-articular ozone injections on outcomes of post-arthroscopic surgery for knee osteoarthritis. Exp Ther Med. 2018;15(6):5323–5329. doi: 10.3892/etm.2018.6101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Feng X., Beiping L. Therapeutic efficacy of ozone injection into the knee for the osteoarthritis patient along with oral celecoxib and glucosamine. J Clin Diagn Res. 2017;11(9):C1–C3. doi: 10.7860/JCDR/2017/26065.10533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Giombini A., Menotti F., Di Cesare A. Comparison between intrarticular injection of hyaluronic acid, oxygen ozone, and the combination of both in the treatment of knee osteoarthrosis. J Biol Regul Homeost Agents. 2016;30(2):621–625. [PubMed] [Google Scholar]
  • 27.Yu B., Chen H.Q., Lu C.H. Effect of intra-articular ozone injection on serum and synovial TNF-alpha, TNFR I, and TNFR II contents in rats with rheumatoid arthritis. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(6):1055–1058. [PubMed] [Google Scholar]
  • 28.Ciborowski M., Lipska A., Godzien J. Combination of LC-MS- and GC-MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood. J Proteome Res. 2012;11(12):6231–6241. doi: 10.1021/pr3008946. [DOI] [PubMed] [Google Scholar]
  • 29.Re L., Martinez-Sanchez G., Bordicchia M. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014;742:158–162. doi: 10.1016/j.ejphar.2014.08.029. [DOI] [PubMed] [Google Scholar]
  • 30.Pecorelli A., Bocci V., Acquaviva A. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol. 2013;267(1):30–40. doi: 10.1016/j.taap.2012.12.001. [DOI] [PubMed] [Google Scholar]
  • 31.Foglieni C., Fulgenzi A., Belloni D. Ozonated autohemotherapy: protection of kidneys from ischemia in rats subjected to unilateral nephrectomy. BMC Nephrol. 2011;12:61. doi: 10.1186/1471-2369-12-61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sancak E.B., Turkon H., Cukur S. Major ozonated autohemotherapy preconditioning ameliorates kidney ischemia-reperfusion injury. Inflammation. 2016;39(1):209–217. doi: 10.1007/s10753-015-0240-z. [DOI] [PubMed] [Google Scholar]
  • 33.Ozkan H., Ekinci S., Uysal B. Evaluation and comparison of the effect of hypothermia and ozone on ischemia-reperfusion injury of skeletal muscle in rats. J Surg Res. 2015;196(2):313–319. doi: 10.1016/j.jss.2015.01.053. [DOI] [PubMed] [Google Scholar]
  • 34.Ozkan H., Ekinci S., Uysal B. Evaluation and comparison of the effect of hypothermia and ozone on ischemia-reperfusion injury of skeletal muscle in rats. J Surg Res. 2015;196(2):313–319. doi: 10.1016/j.jss.2015.01.053. [DOI] [PubMed] [Google Scholar]
  • 35.Cai H.A., Tao X., Zheng L.J. Ozone alleviates ischemia-reperfusion injury by inhibiting mitochondrion-mediated apoptosis pathway in SH-SY5Y cells. Cell Biol Int. 2018 doi: 10.1002/cbin.11294. [DOI] [PubMed] [Google Scholar]
  • 36.Wang L., Chen Z., Weng X. Combined ischemic postconditioning and ozone postconditioning provides synergistic protection against renal ischemia and reperfusion injury through inhibiting pyroptosis. Urology. 2018 doi: 10.1016/j.urology.2018.10.015. [DOI] [PubMed] [Google Scholar]
  • 37.Wang Z., Zhang A., Meng W. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur J Pharmacol. 2018;835:82–93. doi: 10.1016/j.ejphar.2018.07.059. [DOI] [PubMed] [Google Scholar]
  • 38.Meng W., Xu Y., Li D. Ozone protects rat heart against ischemia-reperfusion injury: a role for oxidative preconditioning in attenuating mitochondrial injury. Biomed Pharmacother. 2017;88:1090–1097. doi: 10.1016/j.biopha.2017.01.151. [DOI] [PubMed] [Google Scholar]
  • 39.Sancak E.B., Turkon H., Cukur S. Major ozonated autohemotherapy preconditioning ameliorates kidney ischemia-reperfusion injury. Inflammation. 2016;39(1):209–217. doi: 10.1007/s10753-015-0240-z. [DOI] [PubMed] [Google Scholar]
  • 40.Onal O., Yetisir F., Sarer A.E. Prophylactic ozone administration reduces intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat. Mediat Inflamm. 2015;2015:792016. doi: 10.1155/2015/792016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wu X., Liu X., Huang H. Effects of major ozonated autoheamotherapy on functional recovery, ischemic brain tissue apoptosis and oxygen free radical damage in the rat model of cerebral ischemia. J Cell Biochem. 2018 doi: 10.1002/jcb.27978. [DOI] [PubMed] [Google Scholar]
  • 42.Wu X., Li Z., Liu X. Major ozonated autohemotherapy promotes the recovery of upper limb motor function in patients with acute cerebral infarction. Neural Regen Res. 2013;8(5):461–468. doi: 10.3969/j.issn.1673-5374.2013.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wu X.N., Zhang T., Wang J. Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction. Neural Regen Res. 2016;11(7):1115–1121. doi: 10.4103/1673-5374.187046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Peirone C., Mestre V.F., Medeiros-Fonseca B. Ozone therapy prevents the onset of dysplasia in HPV16-transgenic mice-A pre-clinical efficacy and safety analysis. Biomed Pharmacother. 2018;104:275–279. doi: 10.1016/j.biopha.2018.05.018. [DOI] [PubMed] [Google Scholar]
  • 45.Tirelli U., Cirrito C., Pavanello M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue - a short report. Eur Rev Med Pharmacol Sci. 2018;22(22):8030–8033. doi: 10.26355/eurrev_201811_16432. [DOI] [PubMed] [Google Scholar]
  • 46.Simonetti V., Quagliariello V., Giustetto P. Association of ozone with 5-fluorouracil and cisplatin in regulation of human colon cancer cell viability: in vitro anti-inflammatory properties of ozone in colon cancer cells exposed to lipopolysaccharides. Evid Based Complement Alternat Med. 2017;2017:7414083. doi: 10.1155/2017/7414083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Luongo M., Brigida A.L., Mascolo L. Possible therapeutic effects of ozone mixture on hypoxia in tumor development. Anticancer Res. 2017;37(2):425–435. doi: 10.21873/anticanres.11334. [DOI] [PubMed] [Google Scholar]
  • 48.Delgado-Roche L., Hernandez-Matos Y., Medina E.A. Ozone-oxidative preconditioning prevents doxorubicin-induced cardiotoxicity in sprague-dawley rats. Sultan Qaboos Univ Med J. 2014;14(3):e342–e348. [PMC free article] [PubMed] [Google Scholar]
  • 49.Aslaner A., Cakir T., Celik B. Does intraperitoneal medical ozone preconditioning and treatment ameliorate the methotrexate induced nephrotoxicity in rats? Int J Clin Exp Med. 2015;8(8):13811–13817. [PMC free article] [PubMed] [Google Scholar]
  • 50.Ma Qing, Yang Chaoai, Jiang Xu. Effectiveness of ozonated saline in the treatment of VX2 tumors in rabbits. J Interv Med. 2018;1(3):143–149. doi: 10.19779/j.cnki.2096-3602.2018.03.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
Back to the top